John P. Pigott, MD
Chief Science Officer
John P. Pigott, MD, FACS, is the founder, chairman and chief science officer of VentureMed Group. He is the past director of endovascular surgery at the Jobst Vascular Institute and current Chief Innovation Officer for ProMedica Health Systems in Toledo, Ohio. Dr. Pigott previously completed a fellowship in vascular surgery at the Mayo Clinic. With more than 50 peer-reviewed publications and presentations to his credit, he has spent more than 20 years in the endovascular arena.
In addition, Dr. Pigott has acted as investigator for multiple clinical trials, including peripheral interventions, aortic endografts and chronic total occlusion (CTO) devices, as well as drug and gene therapies. He holds several patents and patents pending for medically related devices to treat peripheral artery disease and aortic pathologies.
Jordan keefe, b.Sc.
Jordan graduated Magna Cum Laude from the University of Toledo with a bachelor's in Chemical Engineering in 2013. Right out of college he spent two years as the Project Manager for IRISense, a medical device startup company working to commercialize a noninvasive glucose monitoring technology. He also worked as a Product Development Specialist for Principle Business Enterprises working to develop products utilizing super-absorbent polymers. He then spent a year working with a web development and IT firm before beginning to pursue his Master's in Computer Science Engineering. Jordan also runs a 501(c)3 organization with his wife, Frances, called Save The Feet where they distribute shoes internationally using a model that is sustainable and beneficial to society. Jordan is also the co-founder of Uptik, a personal financial forecasting application he built from scratch while teaching himself to code. He joined VentureMed in June of 2016 as Project Manager.
Gary L. Smith
Chief Executive Officer
As chief executive officer of VentureMed Group, Gary Smith, brings 30 years of business leadership experience in the medical device, equipment and diagnostics industry to the company. He has successfully led three medical device start-ups from concept through market entry to sales growth. Prior to joining VentureMed, he served as chief executive officer of PrognostiX (Cleveland Heart Lab) and CleveX, both spinouts from Cleveland Clinic Innovations.
kerrie denman, CPA
Kerrie has worked in the public accounting and consulting profession for 20 years. Her career experience generated strong accounting skills as well as communication, presentation, people, and organizational skills. During her senior manager role at Plante & Moran, Kerrie led financial feasibility studies for healthcare companies throughout Ohio and Michigan as well as Illinois and Florida. Kerrie is on the finance committee of Ronald McDonald House. She loves to be involved in sports by either playing, coaching, or spectating!
VP of Sales and Marketing
Dave has over 25 years of experience in medical device and biotech pharmaceutical sales and sales management including the last 17 years in the endovascular device space. Most recently Dave was VP of Sales, Sales Operations and Sales Training for Medtronic's (ev3-->COV) peripheral teams leading both the endo-arterial and endo-venous businesses. Prior to VP of Sales he has held roles of expanding responsibility to include Regional Sales Manager, Area Director of Sales, and Senior Director of Corporate Accounts. Over his career Dave has led expansions of sales teams, integrations post company mergers, and launched new innovative technologies as well as key product portfolio extensions. At VMG, Dave will be responsible for expanding and driving the accountability of the sales team, designing and driving marketing campaigns, KOL development, and most importantly ensuring we hit our revenue goals.
Director OF Sales and Marketing
Jeff has over 15 years of experience, holding various sales and leadership rolls in the medical device and pharmaceutical industries. Prior to joining VentureMed, Jeff was part of the initial commercial sales force for Volcano Corp. (acquired by Philips Healthcare) that was responsible for the launch of the newly approved Phoenix Atherectomy catheter. Jeff has held sales leadership positions with Integra Neurosciences, Foxhollow Technologies, Inc., IDEV Technologies, Inc. and Avinger.